Lohxa Recalls Senna Syrup
The company is voluntarily recalling one lot of Senna Syrup 8.8mg/5mL, unit-dose cups because of microbial contamination.
Lohxa LLC announced on Jan. 11, 2022, that it is voluntarily recalling one lot of Senna Syrup 8.8 mg/5mL, unit-dose cups due to microbial contamination. Senna Syrup is a natural vegetable laxative and is packaged in 5-mL unit-dose cups. The affected lot is AM1115S with expiration date of 01/2023 and was distributed to a wholesaler, AvKare. The product may then have been distributed by AvKare to clinics, hospitals, and healthcare providers.
According to the company, use of the contaminated product could be life threatening in patients who are elderly, have weakened immune systems, or who are at risk for heart inflammation. The company has not, as of the date of the press release, received any reports of adverse events related to the recall.
Source: FDA
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
